4.8 Article

Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using pathogen-like amphiphilic polyanhydride nanoparticles

期刊

BIOMATERIALS
卷 33, 期 18, 页码 4762-4772

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2012.03.027

关键词

Polyanhydrides; Nanoparticles; Carbohydrates; Alveolar macrophages

资金

  1. United States Army Medical Research and Materiel Command [W81XWH-10-1-0806]

向作者/读者索取更多资源

C-type lectin receptors (CLRs) offer unique advantages for tailoring immune responses. Engagement of CLRs regulates antigen presenting cell (APC) activation and promotes delivery of antigens to specific intracellular compartments inside APCs for efficient processing and presentation. In these studies, we have designed an approach for targeted antigen delivery by decorating the surface of polyanhydride nanoparticles with specific carbohydrates to provide pathogen-like properties. Two conserved carbohydrate structures often found on the surface of respiratory pathogens, galactose and di-mannose, were used to functionalize the surface of polyanhydride nanoparticles and target CLRs on alveolar macrophages (AM phi), a principle respiratory tract APC. Co-culture of functionalized nanoparticles with AM(I) significantly increased cell surface expression of MHC I and II, CD86, CD40 and the CLR CIRE over non-functionalized nanoparticles. Di-mannose and galactose functionalization also enhanced the expression of the macrophage mannose receptor (MMR) and the macrophage galactose lectin, respectively. This enhanced AM.:1) activation phenotype was found to be dependent upon nanoparticle internalization. Functionalization also promoted increased AM phi production of the pro-inflammatory cytokines IL-1 beta, IL-6 and TNIF-alpha. Additional studies demonstrated the requirement of the MMR for the enhanced cellular uptake and activation provided by the di-mannose functionalized nanoparticles. Together, these data indicate that targeted engagement of MMR and other CLRs is a viable strategy for enhancing the intrinsic adjuvant properties of nanovaccine adjuvants and promoting robust pulmonary immunity. (C) 2012 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据